Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms

British Journal of Ophthalmology

Volumn 88, Issue 4, 2004, Pages 491-493

  Lake, S ^a,d   Liverani, E ^b   Desai, M ^b   Casson, R ^a   James, B ^c   Clark, A ^b   Salmon, J F ^a  

^a OXFORD EYE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL TENSION GLAUCOMA; OPTIC NERVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 1842609734     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.023366     Document Type: Article

References (19)

1. Roses AD, Saunders AM. ApoE, Alzheimer's disease, and recovery from brain stress. Ann NY Acad Sci 1997;826:200-12.
2. Teasdale GM, Nicoll JA, Murray G, et al. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069-71.
3. Friedman G, Froom P, Sazabon L, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999;52:244-8.
4. Tilley L, Morgan K, Kalsheker N. Genetic risk factors in Alzheimer's disease. J Clin Pathol 1998;51:293-304.
5. Amaratunga A, Abraham CR, Edwards RB, et al. Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J Biol Chem 1996;271:5628-32.
6. Vickers JC, Craig JE, Stankovich J, et al. The apolipoprotein E4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 2002;8:389-93.
7. Collaborative Normal Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497.
8. Hashim Y, Shepherd D, Wiltshire S, et al. Butyrylcholinesterase K variant on chromosome 3q is associated with type II diabetes in white Caucasian subjects. Diabetologia 2001;44:2227-30.
9. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-8.
10. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
11. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-74.
12. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200-6.
13. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353-9.
14. Schmidt S, Saunders AM, De La Paz MA, et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 2000;6:287-93.
15. Huq L, McLachlan T, Hammer HM, et al. An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosa. Lipids 1993;28:995-8.
16. Copin B, Brezin AP, Valtot F, et al. Apolipoprotein E promoter single-nucleotide polymorphisms affect the phenotype of primary open angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 2002;70:1575-81.
17. Lambert J-C, Berr C, Pasquier F, et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998;7:1511-1516.
18. Lambert J-C, Araria-Goumidi L, Myllykangas L, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002;59:59-66.
19. Stengard JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet 1998;103:234-41.